• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Pilot study provides promising results for use of convalescent plasma as treatment for COVID-19

, 26 August 2020/in Corona News, E-News /by 3wmedia

Chinese researchers have for the first time shown in a pilot study that the use of convalescent plasma from cured COVID-19 patients provides promising results in the treatment of others with more severe disease.
In the preprint study at medRxiv (http://doi.org/dqrs; 2020), K. Duan et al. report that the administration of a single, high-dose of neutralizing antibodies is safe and provides encouraging results with regards to the reduction of viral load and improvement of clinical outcomes.
In the study, ten severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents.
After CP transfusion, the level of neutralizing antibody increased rapidly up to 1:640 in five cases, while that of the other four cases maintained at a high level (1:640). All patients showed significant improvement in or complete disappearance of clinical symptoms – including fever, cough, shortness of breath, and chest pain – within 3 days.
The authors state that along with increased oxyhaemoglobin saturation – indicative of recuperating lung function – several parameters also improved, including increased lymphocyte counts and decreased C-reactive protein. Radiological examinations showed varying degrees of absorption of lung lesions within 7 days. The viral load was undetectable after transfusion in seven patients who had previous viremia. No severe adverse effects were observed.
The study shows that CP therapy could potentially improve clinical outcomes through neutralizing viremia in severe COVID-19 cases, however, the authors note that further investigation is needed in larger well-controlled trials to assess the optimal dose and time point.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:35:292020-08-26 14:35:38Pilot study provides promising results for use of convalescent plasma as treatment for COVID-19

More than 9 in 10 surgeons encounter a needlestick injury

, 26 August 2020/in E-News /by 3wmedia

95% of surgeons have either been personally affected by a needlestick injury or have seen a colleague experience one, a new global survey has found, increasing their risk of infection. The survey – the first of its kind undertaken – was conducted by SERMO for Mölnlycke, a wound care and surgical products company.
The survey looked at key opinions from 510 surgeons across six countries relating to infection prevention and the role of high-quality gloves in improving patient and clinician safety. In particular, it demonstrated the importance that surgeons place on high quality gloves in the fight against needlestick injuries and exposure to blood-borne viruses, like HIV.

An estimated two million needlestick injuries occur among health workers each year, resulting in increased exposure to HIV, Hepatitis C
and other blood-borne viruses. Needlestick injuries occur when a needle or other sharp instrument accidentally penetrates the skin, yet the underreporting to occupational health departments is well established.

The survey revealed that 93% of surgeons think that high quality gloves reduce the chance of exposure to blood-borne viruses and 83% said that the quality of gloves affects their sense of being protected from needlestick injuries.

On the topic of patient safety, 81% of surgeons believe that high quality gloves impact overall patient outcomes and 89% agreed that high quality gloves improve patient safety in the operating theatre. When asked about glove failure during an operation, 78% of surgeons responded that it increases the risk of surgical site infections.

Commenting on the survey findings, John Timmons, Clinical Staff Nurse and Internatio-
nal Medical Director, said: “Each year, millions of surgeons and their teams risk exposure to life threatening blood-borne viruses and this ground-breaking survey highlights the value that surgeons across the globe place on high quality gloves. Surgeons clearly recognise their role in both ensuring the safety of surgeons and improving outcomes for patients.

“Surgical gloves are one of the key factors that prevent infections in the operating room and should not be viewed as a commodity. High quality means fewer glove failures, yet we are increasingly seeing healthcare systems around the world prioritise price over quality.”

Healthcare-associated infections (HAIs) are the most frequent adverse event in healthcare delivery worldwide. Hundreds of millions of patients are affected by HAIs worldwide each year, leading to significant mortality rates. Of every 100 hospitalized patients at any given time, an estimated seven patients in developed countries will acquire at least one HAI. www.molnlycke.com/biogel/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:35:292020-08-26 14:35:41More than 9 in 10 surgeons encounter a needlestick injury

Hospital gowns retain superbugs even after disinfectant use

, 26 August 2020/in E-News /by 3wmedia

New research has shown how surgical gowns used in hospitals are retaining superbug Clostridium difficile (C. difficile), even after being treated with the recommended amount of disinfectant.
The research, led by the University of Plymouth, tested single-use hospital surgical gowns (made of polypropylene) that had been infected with three different strains of C. difficile, a bacteria that can cause severe diarrhea, bowel complications and even death.
After treating infected items for ten minutes with disinfectant containing 1,000 parts per million of chlorine – the amount and time recommended by the Department of Health and Social Care– the team found that all strains of C. difficile spores still survived on the gowns and did not reduce, allowing them to potentially transfer to other items.
The research took place because the gowns were suspected to be contributing to C. difficile transmission in a USA hospital. Contaminated gowns from the USA hospital were tested for presence of C. difficile and a deadly 027 type strain was isolated, showing that the gowns can pick up and retain the spores.
In this study, new gowns had the bacteria ‘spiked’ onto them for testing purposes.
Three strains of C. difficile were tested including R20291, which caused severe outbreaks in UK hospitals between 2003 and 2006. This strain is known to cause mortality in patients as it is becoming resistant to the main antibiotic treatments, vancomycin and metronidazole.
To examine the ability of C. difficile to adhere to, and subsequently transfer from, hospital surgical gowns, spores were applied directly to the surgical gowns in water for 10 seconds, 30 seconds, 1 minute, 5 minutes and 10 minutes before being removed and discarded. This was designed to mimic transfer of infectious bodily fluids in the clinical setting and assess the potential for onward transmission to patients.
There was no significant difference between the amount of spores recovered from the gowns and the contact time of the spores to the gowns; suggesting that the spore transfer between surfaces occurred within the first 10 seconds of contact.
The items were then treated with 1,000 ppm chlorine-releasing disinfectant, sodium dichloroisocyanurate (NaDCC) to try and tackle the bug.
Principal investigator and study lead Dr Tina Joshi, part of the Institute of Translational and Stratified Medicine (ITSMed) at the University of Plymouth, explains that this work can be applied to hospitals anywhere in the world, and should help inform future guidelines on infection control and biocides (bacteria killers). She said:
“C. difficile is a really nasty superbug and it’s so important that hospitals stop it from spreading. This study shows that even when we think an item has been suitably cleaned, it hasn’t been necessarily – 1,000 parts per million of chlorine just isn’t enough as the bacteria survived and grew after disinfection.
“As well as possibly upping the concentration of the biocide, the research highlights the need for appropriate hygiene practices. Gowns should not be worn outside of isolated areas as our work has shown that C. difficile spores are good at sticking to clinical surfaces, and can so easily be transferred, causing infections in patients. In an age where infections are becoming resistant to antibiotics, it’s worrying to think that other bacteria are becoming resistant to biocides. So the best thing we can do is ensure that infection control procedures are robust and standardized.”
University of Plymouthhttps://tinyurl.com/yxpr4dhf

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:35:292020-08-26 14:35:45Hospital gowns retain superbugs even after disinfectant use

Tiny generators turn body motion into weight control and wound-healing therapies

, 26 August 2020/in E-News /by 3wmedia

Although electrical stimulation has therapeutic potential for various disorders and conditions, ungainly power sources have hampered practical applications. Now bioengineers have developed implantable and wearable nanogenerators from special materials that create electrical pulses when compressed by body motions. The pulses controlled weight gain and enhanced healing of skin wounds in rat models.
The work was performed by a research team led by Xudong Wang, Ph.D., Professor of Material Sciences and Engineering, College of Engineering, University of Wisconsin-Madison, and supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
The researchers used what are known as piezoelectric and dielectric materials, including ceramics and crystals, which have a special property of creating an electrical charge in response to mechanical stress.
“Wang and colleagues have engineered solutions to a number of technical hurdles to create piezoelectric and dielectric materials that are compatible with body tissues and can generate a reliable, self-sufficient power supply. Their meticulous work has enabled a simple and elegant technology that offers the possibility of developing electrical stimulation therapies for a number of major diseases that currently lack adequate treatments,” explained David Rampulla, Ph.D., director of the Program in Biomaterials and Biomolecular Constructs at NIBIB.
Worldwide, more than 700 million people — over 100 million of them children — are obese, causing health problems such as cardiovascular disease, diabetes, kidney disease, and certain cancers. In 2015 approximately four million people died of obesity-related causes.
To address this crisis, Wang and his colleagues developed a vagal nerve stimulator (VNS) that dramatically improves appetite suppression through electrical stimulation of the vagus nerve. The approach is a promising one that has previously not proven practical because patients must carry bulky battery packs that require proper programming, and frequent recharging.
The VNS consists of a small patch, about the size of a fingernail, which carries tiny devices called nanogenerators. Minimally invasive surgery was used to attach the VNS to the stomachs of rats. The rat’s stomach movements resulted in the delivery of gentle electrical pulses to the vagus nerve, which links the brain to the stomach. With the VNS, when the stomach moved in response to eating, the electric signal told the brain that the stomach was full, even if only a small amount of food was consumed.
The device curbed the rat’s appetite and reduced body weight by a remarkable 40 percent. “The stimulation is a natural response to regulate food intake, so there are no unwanted side effects,” explained Wang. When the device was removed the rats resumed their normal eating patterns and their weight returned to pre-treatment levels.
“Given the simplicity and effectiveness of the system, coupled with the fact that the effect is reversible and carries no side-effects, we are now planning testing in larger animals with the hope of eventually moving into human trials,” said Wang.
In another NIBIB-funded study in a rat experimental model, the researchers used their nanogenerator technology to determine whether electrical stimulation would accelerate healing of wounds on the skin surface.
For this experiment, a band of nanogenerators was placed around the rat’s chest, where the expansion from breathing created a mild electric field. Small electrodes in a bandage-like device were placed over skin wounds on the rat’s back, where they directed the electric field to cover the wound area.
The technique reduced healing times to just three days compared with nearly two weeks for the normal healing process.
Similar to the case with appetite suppression, it was known that electricity could enhance wound healing, but the devices that had been developed were large and impractical. The nanogenerator-powered bandage is completely non-invasive and produced a mild electric field that is similar to electrical activity detected in the normal wound-healing process.
The researchers observed electrical activation of normal cellular healing processes that included the movement of healthy skin fibroblasts into the wound, accompanied by the release of biochemical factors that promote the growth of the fibroblasts and other cell types that expand to repair the wound space.
“The dramatic decrease in healing time was surprising,” said Wang, “We now plan to test the device on pigs because their skin is very similar to humans.”
The team believes the simplicity of the electric bandage will help move the technology to human trials quickly. In addition, Wang explained that the fabrication of the device is very inexpensive and a product for human use would cost about the same as a normal bandage.
NIBIB https://tinyurl.com/y3cxut6p

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:35:292020-08-26 14:35:52Tiny generators turn body motion into weight control and wound-healing therapies
Page 240 of 240«‹238239240

Latest issue of International Hospital

April 2024

2 June 2026

DeepHealth achieves multiple regulatory milestones for Neuro, Prostate and LumbarMR

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription